RA0004

antibody from Oursmab

Targeting: ADAM9 CORD9, KIAA0021, MCMP, MDC9, Mltng

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0004

Provider

Oursmab

Product name

Izeltabart (Biosimilar Reference Antibody) (ADAM9)

Antibody type

Monoclonal

Description

Izeltabart is a high-affinity, humanized monoclonal antibody that specifically targets ADAM9 (A Disintegrin And Metalloproteinase 9). Its primary mechanism of action is designed to inhibit the proteolytic and signaling functions of ADAM9, a protein that plays a critical role in tumor progression, metastasis, and resistance to therapy. By blocking ADAM9, Izeltabart aims to interfere with cancer cell invasion, tumor-stroma interactions, and growth factor shedding, thereby potentially suppressing tumor growth and spread. It is under investigation as a potential therapeutic agent for various solid tumors, particularly those with high ADAM9 expression.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.